Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
ORI-1001 antisense oligonucleotide stifles human papillomavirus replication
June 23rd, 2005
ORI-1001 antisense oligonucleotide stifles human papillomavirus replication. "Human papillomaviruses (HPVs) are small double-stranded DNA viruses that infect the cutaneous or mucosal epithelium. The high-risk genital HPVs are associated with squamous intraepithelial lesions of the anogenital region that can progress to cancer," researchers in the United States report. "Cervical cancer is the third leading cause of cancer death in women worldwide, yet there are no specific therapeutic treatments for HPV-associated malignancies," according to S. Alam and colleagues, Pennsylvania State University. "Development of specific antisense...
Source: Women's Health Weekly (2005-06-23)
|
